CD4 and infectious disease: RP have been proposed as potential vaccine targets in several infectious diseases, including as a cross-species protective protein in different Leishmania species52, and as a CD4+ T cell-specific epitope in tuberculosis that can be boosted in mice previously primed with BCG mice53.